Ceruloplasmin is a copper-carrying protein made by the liver. A low ceruloplasmin blood test means the amount of this protein in your blood is below the lab’s reference range, but the result does not point to one diagnosis by itself. The two main possibilities are very different: copper deficiency, where the body does not have enough usable copper, and Wilson disease, where copper builds up in organs because the body cannot remove it normally.
The pattern matters more than the single number. Serum copper, 24-hour urine copper, liver tests, blood counts, symptoms, medications, supplements, age, pregnancy status, and family history all change the meaning. A low result may be important in someone with unexplained anemia, low white blood cells, numbness, gait problems, liver disease, tremor, psychiatric changes, or a family history of Wilson disease. It may also be misleading when taken out of context.
- Low ceruloplasmin is often defined as below about 20 mg/dL, or 0.20 g/L, but each lab sets its own range.
- Wilson disease usually causes low ceruloplasmin with increased urine copper and signs of liver, neurologic, psychiatric, or eye involvement.
- Copper deficiency usually causes low ceruloplasmin with low serum copper and low or normal urine copper.
- Excess zinc, bariatric surgery, malabsorption, poor intake, and long-term tube feeding can cause copper deficiency.
- No special preparation is usually needed for a ceruloplasmin blood test.
- Severe jaundice, confusion, sudden weakness, trouble walking, or anemia with dark urine needs prompt medical care.
Table of Contents
- What a Low Ceruloplasmin Result Means
- How Ceruloplasmin and Copper Work Together
- Common Causes of Low Ceruloplasmin
- Copper Deficiency or Wilson Disease: How Doctors Tell the Difference
- Symptoms That Change the Meaning of a Low Result
- Follow-Up Tests and Result Patterns
- What Happens Next After a Low Ceruloplasmin Result
- Common Mistakes and Special Situations
What a Low Ceruloplasmin Result Means
A low ceruloplasmin result means your blood contains less ceruloplasmin than expected for your age and lab method. In many adults, a value below about 20 mg/dL is considered low or borderline low. Some labs report in g/L, where 20 mg/dL equals 0.20 g/L. Other labs use broader ranges, such as roughly 20–35 mg/dL or 20–60 mg/dL, so the reference interval printed next to your result should guide the first interpretation.
A low number does not automatically mean “low copper” or “copper toxicity.” Ceruloplasmin carries most of the copper measured in a standard serum copper test. When ceruloplasmin drops, total serum copper often drops too, even if copper is accumulating in the liver or brain in Wilson disease. That is why doctors often pair ceruloplasmin with a serum copper blood test and urine copper testing.
Ceruloplasmin is also an acute-phase reactant, meaning it can rise during inflammation, infection, pregnancy, estrogen therapy, and some other stress states. This creates a confusing situation: a person may have Wilson disease or low copper stores, but inflammation may push ceruloplasmin toward normal. A normal result does not always rule out copper-related disease when symptoms and other tests point in that direction.
Borderline low versus very low
A mildly low result, such as 17–19 mg/dL, needs context. It may reflect early copper deficiency, carrier status for a Wilson disease gene variant, lab variation, low protein status, or another mild influence. A very low result, especially below 10 mg/dL, raises stronger concern for a disorder of copper metabolism, severe copper deficiency, or a rare condition such as aceruloplasminemia. Values below 5 mg/dL are unusual and deserve careful follow-up.
One helpful way to read the result is to ask: “Is ceruloplasmin low because copper is not being absorbed, because copper is not being attached to ceruloplasmin properly, or because protein production or protein retention is impaired?” The answer usually comes from follow-up testing, not from the ceruloplasmin number alone.
How Ceruloplasmin and Copper Work Together
Ceruloplasmin is made in the liver. The liver attaches copper to the ceruloplasmin protein and releases it into the blood. Once in circulation, ceruloplasmin carries most of the copper found in serum and helps iron move normally through the body. Its ferroxidase activity helps convert iron into a form that can bind transferrin, the main iron-transport protein.
Copper is needed in tiny amounts, but it supports several important systems. It helps enzymes involved in energy production, connective tissue strength, nervous system function, antioxidant defenses, pigment production, and iron handling. Too little usable copper can cause anemia, low neutrophils, fragile bones, numbness, tingling, gait problems, and spinal cord dysfunction. Too much free or poorly handled copper can damage the liver, brain, eyes, kidneys, and red blood cells.
This is why ceruloplasmin sits at the crossroads of copper and iron interpretation. A person with copper deficiency may look like they have iron deficiency, anemia of chronic disease, vitamin B12 deficiency, or even a bone marrow disorder. A person with Wilson disease may have low total serum copper, even though copper is building up in tissues. The result only becomes meaningful when it is linked to symptoms and paired with copper studies.
Copper balance also explains why zinc matters. Zinc and copper compete during absorption in the gut. Long-term high-dose zinc supplements, some denture adhesives that contain zinc, and Wilson disease treatment with zinc can reduce copper absorption enough to cause deficiency. This is one reason a history of supplements is not a minor detail; it can change the entire interpretation of a low ceruloplasmin result.
Common Causes of Low Ceruloplasmin
Low ceruloplasmin has several causes, and they do not all have the same urgency. Some point toward low copper availability. Others point toward a genetic copper transport problem. Some reflect protein loss or reduced protein production rather than a primary copper disorder.
| Possible cause | Typical pattern | Clues that support it |
|---|---|---|
| Copper deficiency | Low ceruloplasmin, low serum copper, low or normal urine copper | Zinc use, bariatric surgery, malabsorption, poor intake, tube feeding, anemia, neutropenia, neuropathy |
| Wilson disease | Low ceruloplasmin, often low total serum copper, increased urine copper | Liver disease, tremor, movement changes, psychiatric symptoms, Kayser-Fleischer rings, family history |
| Protein loss | Low ceruloplasmin with other low blood proteins | Kidney protein loss, intestinal protein loss, swelling, low albumin |
| Advanced liver disease | Reduced protein production may lower ceruloplasmin | Abnormal liver enzymes, low albumin, high INR, jaundice, cirrhosis signs |
| Menkes disease or related ATP7A disorder | Low copper and low ceruloplasmin, usually in infancy for classic Menkes disease | Infant developmental problems, seizures, poor growth, sparse or kinky hair |
| Aceruloplasminemia | Very low or absent ceruloplasmin | Iron overload pattern, diabetes, neurologic symptoms, family history |
Copper deficiency
Copper deficiency is one of the most important non-Wilson causes of low ceruloplasmin. It can happen when intake is too low, absorption is impaired, or zinc intake blocks copper absorption. The risk is higher after gastric bypass, gastrectomy, some intestinal surgeries, long-term parenteral nutrition without enough copper, prolonged tube feeding, inflammatory bowel disease, celiac disease, and other malabsorption conditions.
Copper deficiency can affect blood cells and nerves. A complete blood count may show anemia, low neutrophils, or sometimes multiple low cell lines. The anemia may be microcytic, normocytic, or macrocytic, so the red blood cell size does not reliably separate copper deficiency from iron, folate, or B12 problems. Copper deficiency can also mimic myelodysplastic syndrome on bone marrow testing, which makes early recognition valuable.
Neurologic copper deficiency may look like vitamin B12 deficiency. People may develop numbness, tingling, poor balance, difficulty walking, leg stiffness, loss of vibration sense, or spinal cord changes on MRI. Blood counts may improve after copper is replaced, but nerve recovery can be incomplete if treatment is delayed.
Wilson disease
Wilson disease is a genetic disorder caused by harmful variants in the ATP7B gene. The liver cannot move copper into bile normally, so copper accumulates in the liver and later spills into the blood and other organs. At the same time, copper is not attached normally to ceruloplasmin. The unstable copper-free form of ceruloplasmin breaks down faster, so the measured ceruloplasmin level often falls.
Wilson disease can present as hepatitis, fatty liver, cirrhosis, acute liver failure, tremor, dystonia, trouble speaking, trouble swallowing, personality changes, depression, anxiety, psychosis, hemolytic anemia, kidney problems, or eye findings. It can appear in children, teenagers, or adults. Although many cases appear before age 40, age alone should not be used to dismiss the possibility when the pattern fits.
A low ceruloplasmin result is not enough to diagnose Wilson disease. The diagnosis usually uses a combination of tests: 24-hour urine copper, slit-lamp eye exam for Kayser-Fleischer rings, liver tests, possible liver copper measurement, and ATP7B genetic testing. A person with possible Wilson disease should not start copper supplements unless a clinician has clearly ruled out copper overload.
Protein loss or reduced liver protein production
Ceruloplasmin is a protein, so it may fall when the body loses proteins through the kidneys or intestines. Nephrotic syndrome, severe protein-losing enteropathy, and marked malnutrition can lower several blood proteins at the same time. In these cases, low albumin, swelling, foamy urine, diarrhea, weight loss, or abnormal urine protein may help identify the cause.
The liver also makes ceruloplasmin. Severe liver disease can reduce production of proteins, including albumin, clotting factors, and sometimes ceruloplasmin. This can overlap with Wilson disease because Wilson disease itself can cause liver disease. A broader liver function test panel helps separate mild enzyme changes from impaired liver synthetic function.
Menkes disease and aceruloplasminemia
Menkes disease is a rare inherited copper transport disorder, usually seen in infancy. Babies may appear normal at birth and later develop poor growth, low muscle tone, seizures, developmental delay, and sparse, twisted, lightly colored hair. Serum copper and ceruloplasmin are low, but healthy young infants also have naturally low levels, so infant testing requires specialist interpretation.
Aceruloplasminemia is another rare genetic disorder. In this condition, ceruloplasmin is extremely low or absent, and iron builds up in tissues. It is different from Wilson disease and from ordinary copper deficiency. Diabetes, anemia, retinal changes, movement problems, and neurologic symptoms may appear over time.
Copper Deficiency or Wilson Disease: How Doctors Tell the Difference
Copper deficiency and Wilson disease can both show low ceruloplasmin and low total serum copper, but they usually differ in urine copper and clinical pattern. In copper deficiency, the body is short on usable copper, so urine copper is often low or not elevated. In Wilson disease, copper is trapped and mishandled, so urine copper is usually increased, especially in symptomatic disease.
The distinction is important because treatment goes in opposite directions. Copper deficiency is treated with copper replacement and removal of the cause, such as excess zinc. Wilson disease is treated by reducing toxic copper burden and preventing future accumulation, usually with chelating medicines or zinc therapy under specialist care.
| Feature | Copper deficiency | Wilson disease |
|---|---|---|
| Main problem | Too little usable copper | Impaired copper removal and tissue copper buildup |
| Serum copper | Usually low | Often low total serum copper, despite tissue copper excess |
| 24-hour urine copper | Often low or normal | Usually elevated, especially with symptoms |
| Common clues | Zinc excess, bariatric surgery, malabsorption, anemia, neutropenia, neuropathy | Liver disease, neurologic or psychiatric symptoms, Kayser-Fleischer rings, family history |
| Typical treatment direction | Replace copper and correct the cause | Remove or block copper under specialist supervision |
| Main risk of misreading the result | Missing a treatable deficiency | Giving copper when copper overload is present |
A simple example shows why this matters. A 55-year-old person with prior gastric bypass, numb feet, low neutrophils, low ceruloplasmin, low serum copper, and low urine copper fits copper deficiency more than Wilson disease. A 19-year-old with hepatitis, tremor, low ceruloplasmin, high urine copper, and Kayser-Fleischer rings fits Wilson disease more than copper deficiency.
Some cases remain mixed or unclear. A person being treated for Wilson disease can become copper deficient if treatment is too strong, especially with high-dose zinc or chelation. Someone with chronic liver disease from another cause can have low ceruloplasmin without Wilson disease. A carrier for one ATP7B variant may have mildly low ceruloplasmin but not full Wilson disease. In these situations, a clinician may need repeat testing, genetic testing, liver copper measurement, or specialist review.
Symptoms That Change the Meaning of a Low Result
A low ceruloplasmin result becomes more significant when symptoms match a copper disorder. It is less concerning when it is only slightly low, other copper tests are normal, and there are no symptoms or risk factors. Still, symptoms can be subtle, and some people with Wilson disease are found through family screening before major illness appears.
Liver symptoms
Liver-related symptoms raise concern for Wilson disease, severe liver disease, or another liver condition affecting protein production. Concerning signs include yellow skin or eyes, dark urine, pale stools, itching, abdominal swelling, easy bruising, vomiting blood, confusion, marked fatigue, and pain or fullness in the right upper abdomen.
Liver blood tests may show high ALT or AST, high bilirubin, abnormal alkaline phosphatase, low albumin, or prolonged INR. In Wilson-related acute liver failure, hemolytic anemia may occur at the same time. This combination needs urgent evaluation.
Neurologic and psychiatric symptoms
Neurologic symptoms can occur in both copper deficiency and Wilson disease, but they often look different. Copper deficiency more often affects the spinal cord and peripheral nerves, causing numbness, tingling, sensory loss, balance trouble, leg stiffness, and difficulty walking. Wilson disease more often causes movement and coordination problems, such as tremor, dystonia, rigidity, slurred speech, drooling, trouble swallowing, and abnormal movements.
Psychiatric symptoms can also appear in Wilson disease. Depression, anxiety, personality changes, irritability, poor school or work performance, impulsivity, and psychosis may occur before the diagnosis is clear. These symptoms are common in the general population, so they do not diagnose Wilson disease on their own. They become more meaningful when paired with liver abnormalities, movement symptoms, eye findings, family history, or abnormal copper studies.
Blood count symptoms
Copper deficiency often affects blood cell production. Symptoms may include fatigue, shortness of breath with exertion, frequent infections, mouth sores, pale skin, or unexplained bruising. The CBC may show anemia, neutropenia, or pancytopenia. A low ceruloplasmin result with anemia and neutropenia should prompt copper testing, especially when iron, B12, and folate results do not explain the problem.
Wilson disease can also affect blood cells, especially during hemolysis, where red blood cells break down too quickly. Dark urine, jaundice, back pain, sudden anemia, and high bilirubin can be warning signs.
Infant and childhood clues
In infants, low ceruloplasmin needs age-aware interpretation because newborns and young babies normally have lower copper and ceruloplasmin than older children and adults. Classic Menkes disease is usually suspected from the full clinical picture, not from the blood test alone. Poor feeding, seizures, low muscle tone, developmental delay, failure to thrive, unusual hair texture, and low copper studies need pediatric specialist evaluation.
Children and teenagers with Wilson disease may present with liver disease before neurologic symptoms appear. Unexplained hepatitis, fatty liver, cirrhosis, hemolytic anemia, or family history of Wilson disease should lead to a focused copper evaluation.
Follow-Up Tests and Result Patterns
A low ceruloplasmin result usually leads to a small group of follow-up tests. The exact order depends on symptoms, age, pregnancy status, liver findings, and whether copper deficiency or Wilson disease is more likely.
Common follow-up tests include:
- Serum copper
- 24-hour urine copper
- Complete blood count with differential
- Liver enzymes, bilirubin, albumin, and INR
- Serum zinc, especially if supplements or denture adhesive are used
- Ferritin, serum iron, transferrin saturation, B12, and folate when anemia is present
- Slit-lamp eye exam for Kayser-Fleischer rings when Wilson disease is possible
- ATP7B genetic testing when Wilson disease remains possible
- Liver copper measurement when noninvasive testing remains unclear
The 24-hour urine copper test is especially helpful because it often separates copper deficiency from Wilson disease. Collection quality matters. The container must be appropriate for trace elements, and the full 24-hour sample must be collected. Missed urine, contamination, or the wrong container can distort the result.
Patterns that suggest copper deficiency
Copper deficiency is more likely when ceruloplasmin is low, serum copper is low, and urine copper is low or not elevated. The history often reveals a reason: high zinc intake, prior upper gastrointestinal surgery, malabsorption, long-term nutrition support, low dietary intake, or over-treatment of Wilson disease. Anemia and neutropenia strengthen the pattern.
A person with suspected copper deficiency often needs a careful review of supplements. Zinc may appear in immune products, multivitamins, cold remedies, and denture creams. Long-term intake above the usual daily requirement can matter, especially when copper intake is low. Related testing may include a high zinc blood test interpretation when excess zinc is suspected.
Patterns that suggest Wilson disease
Wilson disease is more likely when ceruloplasmin is low and 24-hour urine copper is elevated, especially with liver disease, neurologic findings, psychiatric changes, Kayser-Fleischer rings, or family history. Many symptomatic patients have urine copper above 100 mcg per 24 hours, though lower abnormal values may still matter in the right setting.
Serum copper can confuse people because total serum copper may be low in Wilson disease. This happens because ceruloplasmin-bound copper makes up most measured serum copper. Non-ceruloplasmin-bound copper is more relevant to toxicity, but calculated “free copper” can be inaccurate when the input tests are imperfect. Specialized exchangeable copper tests are being studied and used in some settings, but availability varies.
Patterns that suggest protein loss or liver synthetic problems
Low ceruloplasmin with low albumin, swelling, and high urine protein may point toward kidney protein loss. Low ceruloplasmin with diarrhea, weight loss, low immunoglobulins, or low lymphocytes may suggest intestinal protein loss. Low ceruloplasmin with high INR and low albumin may reflect impaired liver protein production.
These patterns do not rule out Wilson disease. They tell the clinician to interpret the copper tests alongside the broader illness rather than relying on ceruloplasmin alone.
What Happens Next After a Low Ceruloplasmin Result
The next step depends on how low the result is and why the test was ordered. A mild low result found during general screening may need repeat testing and paired copper studies. A low result in a person with liver disease, neurologic symptoms, anemia, or a family history of Wilson disease needs a more complete evaluation.
Do not treat the number before the cause is clear. Copper supplements may be appropriate for proven deficiency, but they can be harmful if Wilson disease or another copper overload state is present. On the other side, zinc therapy or chelation for presumed Wilson disease can worsen copper deficiency if the diagnosis is wrong or if treatment is excessive.
When copper deficiency is confirmed
Treatment usually includes copper replacement and removal of the cause. The dose and route depend on severity, symptoms, absorption, and the clinician’s judgment. Some people respond to oral copper. Severe deficiency, malabsorption, or neurologic disease may require more intensive replacement. If excess zinc caused the deficiency, zinc must be stopped or reduced unless there is a strong medical reason to continue it.
Blood counts often improve faster than neurologic symptoms. Anemia and neutropenia may improve over weeks. Numbness, gait problems, and spinal cord symptoms may take months and may not fully reverse. Early treatment gives the best chance of preventing permanent nerve damage.
Follow-up usually includes serum copper, ceruloplasmin, CBC, zinc if relevant, and symptom tracking. People with ongoing malabsorption or altered anatomy after surgery may need long-term monitoring.
When Wilson disease is suspected or confirmed
Wilson disease needs specialist care, usually from a hepatologist, neurologist, or a center experienced with copper disorders. Treatment is lifelong. Common treatment approaches include copper chelators, which increase copper removal, and zinc salts, which reduce copper absorption. The best choice depends on symptoms, liver status, neurologic status, pregnancy, tolerance, and treatment history.
Family screening is often important. Wilson disease is inherited in an autosomal recessive pattern, meaning siblings of an affected person may be at risk. Testing relatives can find disease before serious symptoms develop.
Monitoring is not based on ceruloplasmin alone. Doctors often follow urine copper, serum copper, liver tests, blood counts, neurologic status, treatment adherence, and signs of over-treatment. Too much treatment can push a person into copper deficiency, so both copper overload and copper depletion need attention.
When results are borderline
Borderline results are common. A clinician may repeat ceruloplasmin and copper tests when inflammation has settled, supplements have been reviewed, or collection errors are possible. They may also compare results with albumin, CRP, estrogen exposure, pregnancy status, and liver function.
A borderline low ceruloplasmin with normal urine copper, normal serum copper, normal liver tests, and no symptoms may be watched rather than treated. A borderline low result with abnormal liver tests, neurologic symptoms, or a family history of Wilson disease deserves more workup.
Common Mistakes and Special Situations
The most common mistake is treating low ceruloplasmin as a diagnosis. It is a clue. It can support copper deficiency, Wilson disease, protein loss, liver disease, or a rare genetic disorder, but it cannot separate them alone.
Another mistake is assuming that low total serum copper always means copper deficiency. In Wilson disease, total serum copper may be low because ceruloplasmin is low, even while copper is accumulating in the liver and brain. Urine copper and clinical context are essential.
A third mistake is ignoring zinc. Zinc is often viewed as harmless because it is sold over the counter, but long-term high intake can cause clinically important copper deficiency. People taking zinc for immunity, acne, macular degeneration, colds, or Wilson disease should know whether the dose is short-term, long-term, balanced with copper, and medically monitored.
Pregnancy and estrogen therapy can raise ceruloplasmin. Inflammation can raise it too. This may hide an otherwise low value. A normal ceruloplasmin result is less reassuring when Wilson disease symptoms or copper deficiency risk factors are strong.
Infant testing is another special case. Young infants naturally have lower copper and ceruloplasmin, so pediatric interpretation differs from adult interpretation. A low value in a baby must be read with age-specific ranges, symptoms, and sometimes genetic testing.
People with anemia may also need a wider nutritional workup. Copper deficiency can overlap with iron, B12, or folate problems, especially after bariatric surgery or malabsorption. If anemia is present, related tests may include ferritin, transferrin saturation, B12, folate, reticulocyte count, and sometimes a low copper blood test evaluation.
A careful supplement and medication list can prevent months of confusion. Bring the actual bottles or a photo of the labels. Include multivitamins, minerals, zinc, iron, copper, vitamin C, denture adhesives, protein powders, tube-feeding formulas, and any Wilson disease medications. The doses, not just the product names, matter.
Questions to ask your clinician
Useful questions after a low ceruloplasmin result include:
- How low is the result compared with this lab’s reference range?
- Do my serum copper and 24-hour urine copper fit copper deficiency or Wilson disease?
- Should I stop zinc or other mineral supplements while this is being evaluated?
- Do my blood count, liver tests, and symptoms point toward a specific cause?
- Do I need an eye exam for Kayser-Fleischer rings?
- Should my family members be tested for Wilson disease?
- How soon should the test be repeated?
- What symptoms should make me seek urgent care?
A low ceruloplasmin result deserves a clear explanation, but it should not cause panic. Many causes are treatable once the pattern is recognized. The safest path is to confirm whether the issue is copper deficiency, copper overload, protein loss, liver production, or a rare inherited disorder before starting supplements or copper-lowering treatment.
References
- Ceruloplasmin Test 2023 (Official Medical Test)
- A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases 2022 (Guideline)
- Wilson Disease 2023 (GeneReviews)
- Biochemical diagnosis of Wilson’s disease: an update 2023 (Review)
- ATP7A-Related Copper Transport Disorders 2021 (GeneReviews)
- Copper deficiency myelopathy mimicking cervical spondylitic myelopathy: a systematic review of the literature with case report 2024 (Systematic Review)
Disclaimer
A low ceruloplasmin result should be interpreted by a qualified healthcare professional, especially when Wilson disease, copper deficiency, liver disease, pregnancy, infancy, or neurologic symptoms are involved. Do not start copper supplements, zinc therapy, or chelation treatment based only on ceruloplasmin without confirming the cause. Seek urgent medical care for severe jaundice, confusion, sudden weakness, dark urine with anemia symptoms, vomiting blood, or rapidly worsening neurologic symptoms.
